Merck’s new formulation of the mega-blockbuster Keytruda, made in collaboration with Alteogen, could help to keep the drug’s ...

Proof of principle data from Phase I part of the Phase I/II trial of TG4050 in the adjuvant setting of head and neck cancer. All TG4050-treated patients remained disease-free after median follow-up of ...

DelveInsight’s, “Colorectal Cancer Pipeline Insight 2025” report provides comprehensive insights about 195+ companies and ...

Merck's revenues are driven by cancer med Keytruda, which faces patent expiry by 2028. See why I rate MRK stock a hold.

Expression data from patient-derived xenograft (PDX) mouse models exposed to micvotabart pelidotin (MICVO) indicate gene signatures associated ...

We recently published a list of 13 Best Healthcare Dividend Stocks to Invest in. In this article, we are going to take a look ...

Merck and Bristol-Myers Squibb are key players in cancer treatment. Find out why MRK and BMY stocks have different prospects ...

Initiated Phase 1/2 combination study of micvotabart pelidotin and Merck’s anti-PD-1 therapy, KEYTRUDA ® (pembrolizumab), in patients with R/M HNSCC and other advanced ... “Risk Factors” set forth in ...

Also Instruction that access strongly ordered or Device memory is never abandoned when they have started accessing the memory Where as in Cortex –M it starts from where it left (other than divide ...

M.R. Doreswamy, 88, passed away on Thursday evening at his residence in Banashankari II Stage, Bengaluru. He is survived by his wife, son, daughter and grandchildren. The mortal remains will be ...

Given the economic conditions in China, Merck withdrew its previously issued long-term guidance of generating more than $11 billion in sales form Gardasil by 2030. Proquad, M-M-R II and Varivax ...

As DC Studios waits for Reeves’ completed script to come in, Pattinson and co-star Andy Serkis are aware of Batman Part II plot details. Obviously, neither actor could share specific story beats ...